Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
- DOI
- 10.1158/1078-0432.ccr-20-4928
- Published
- 2021 Jun 15
- Container
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-20-4928,
title = {Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).},
author = {Vernieri C and Nichetti F and Lalli L and Moscetti L and Giorgi CA and Griguolo G and Marra A and Randon G and Rea CG and Ligorio F and Scagnoli S and De Angelis C and Molinelli C and Fabbri A and Ferraro E and Trapani D and Milani A and Agostinetto E and Bernocchi O and Catania G and Vantaggiato A and Palleschi M and Moretti A and Basile D and Cinausero M and Ajazi A and Castagnoli L and Lo Vullo S and Gerratana L and Puglisi F and La Verde N and Arpino G and Rocca A and Ciccarese M and Pedersini R and Fabi A and Generali D and Losurdo A and Montemurro F and Curigliano G and Del Mastro L and Michelotti A and Cortesi E and Guarneri V and Pruneri G and Mariani L and de Braud F},
year = {2021},
journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
doi = {10.1158/1078-0432.ccr-20-4928},
url = {https://doi.org/10.1158/1078-0432.ccr-20-4928}
}RIS
TY - JOUR TI - Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET). AU - Vernieri C AU - Nichetti F AU - Lalli L AU - Moscetti L AU - Giorgi CA AU - Griguolo G AU - Marra A AU - Randon G AU - Rea CG AU - Ligorio F AU - Scagnoli S AU - De Angelis C AU - Molinelli C AU - Fabbri A AU - Ferraro E AU - Trapani D AU - Milani A AU - Agostinetto E AU - Bernocchi O AU - Catania G AU - Vantaggiato A AU - Palleschi M AU - Moretti A AU - Basile D AU - Cinausero M AU - Ajazi A AU - Castagnoli L AU - Lo Vullo S AU - Gerratana L AU - Puglisi F AU - La Verde N AU - Arpino G AU - Rocca A AU - Ciccarese M AU - Pedersini R AU - Fabi A AU - Generali D AU - Losurdo A AU - Montemurro F AU - Curigliano G AU - Del Mastro L AU - Michelotti A AU - Cortesi E AU - Guarneri V AU - Pruneri G AU - Mariani L AU - de Braud F PY - 2021 JO - Clinical cancer research : an official journal of the American Association for Cancer Research DO - 10.1158/1078-0432.ccr-20-4928 UR - https://doi.org/10.1158/1078-0432.ccr-20-4928 ER -
APA
C, V., F, N., L, L., L, M., CA, G., G, G., A, M., G, R., CG, R., F, L., S, S., C, D. A., C, M., A, F., E, F., D, T., A, M., E, A., O, B., G, C., A, V., M, P., A, M., D, B., M, C., A, A., L, C., S, L. V., L, G., F, P., N, L. V., G, A., A, R., M, C., R, P., A, F., D, G., A, L., F, M., G, C., L, D. M., A, M., E, C., V, G., G, P., L, M., & F, D. B. (2021). Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-20-4928
Source records
- pubmed · retrieved 2026-09-27T13:41:52.016Z
- europe-pmc · retrieved 2026-09-27T13:41:52.031Z